Shell (SHEL) 6-K 1 Aug 24 2024 Q2 Current report (foreign) Financial data

Cover Page

Cover Page	6 Months Ended
	Jun. 30, 2024
Cover [Abstract]
Document Type	6-K
Entity File Number	1-32575
Entity Registrant Name	Shell plc
Amendment Flag	false
Document Period End Date	Jun. 30, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Entity Central Index Key	0001306965
Current Fiscal Year End Date	--12-31

CONSOLIDATED STATEMENT OF INCOM

CONSOLIDATED STATEMENT OF INCOME - USD ($) $ in Millions		3 Months Ended			6 Months Ended
		Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Profit or loss [abstract]
Third-party revenue	[1]	$ 74,463	$ 72,478	$ 74,578	$ 146,942	$ 161,538
Share of profit/(loss) of joint ventures and associates		898	1,318	629	2,216	2,210
Interest and other income/(expenses)	[2]	(305)	907	813	602	1,294
Total revenue and other income/(expenses)		75,057	74,703	76,020	149,760	165,041
Purchases		49,417	46,867	51,492	96,284	108,994
Production and manufacturing expenses		5,593	5,810	6,041	11,403	12,049
Selling, distribution and administrative expenses		3,094	2,975	3,314	6,069	6,365
Research and development		263	212	297	475	550
Exploration		496	750	444	1,246	847
Depreciation, depletion and amortisation	[2]	7,555	5,881	7,872	13,436	14,157
Interest expense		1,235	1,164	1,211	2,399	2,375
Total expenditure		67,653	63,659	70,671	131,312	145,339
Income/(loss) before taxation		7,404	11,044	5,348	18,447	19,702
Taxation charge/(credit)	[2]	3,754	3,604	2,195	7,358	7,776
Income/(loss) for the period	[1]	3,650	7,439	3,154	11,089	11,926
Income/(loss) attributable to non-controlling interest		133	82	20	215	83
Income/(loss) attributable to Shell plc shareholders		$ 3,517	$ 7,358	$ 3,134	$ 10,874	$ 11,843
Basic earnings per share ($ per share)	[3]	$ 0.55	$ 1.14	$ 0.46	$ 1.70	$ 1.73
Diluted earnings per share ($ per share)	[3]	$ 0.55	$ 1.13	$ 0.46	$ 1.68	$ 1.71
[1] See Note 2 “Segment information”. See Note 8 “Other notes to the unaudited Condensed Consolidated Interim Financial Statements”. 3 See Note 4 “Earnings per share”.

CONSOLIDATED STATEMENT OF COMPR

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME - USD ($) $ in Millions		3 Months Ended			6 Months Ended
		Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Statement of comprehensive income [abstract]
Income/(loss) for the period	[1]	$ 3,650	$ 7,439	$ 3,154	$ 11,089	$ 11,926
Items that may be reclassified to income in later periods:
– Currency translation differences	[2]	698	(1,995)	(267)	(1,296)	286
– Debt instruments remeasurements		(12)	(6)	(7)	(19)	12
– Cash flow hedging gains/(losses)		14	53	100	67	(80)
– Net investment hedging gains/(losses)		0	0	8	0	(44)
– Deferred cost of hedging		(6)	(14)	(53)	(20)	(55)
– Share of other comprehensive income/(loss) of joint ventures and associates		(50)	(12)	(10)	(62)	(46)
Total		644	(1,974)	(229)	(1,330)	73
Items that are not reclassified to income in later periods:
– Retirement benefits remeasurements		310	439	(24)	749	(55)
– Equity instruments remeasurements		(81)	78	16	(3)	23
– Share of other comprehensive income/(loss) of joint ventures and associates		44	10	(24)	55	(32)
Total		273	528	(32)	801	(65)
Other comprehensive income/(loss) for the period		917	(1,445)	(261)	(529)	8
Comprehensive income/(loss) for the period		4,567	5,994	2,893	10,560	11,934
Comprehensive income/(loss) attributable to non-controlling interest		123	56	(15)	180	68
Comprehensive income/(loss) attributable to Shell plc shareholders		$ 4,443	$ 5,937	$ 2,908	$ 10,381	$ 11,866
[1] See Note 2 “Segment information”. 1. See Note 8 “Other notes to the unaudited Condensed Consolidated Interim Financial Statements”.

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEET - USD ($) $ in Millions		Jun. 30, 2024		Dec. 31, 2023
Non-current assets
Goodwill		$ 16,538	[1]	$ 16,660
Other intangible assets		9,387		10,253
Property, plant and equipment		189,656		194,835
Joint ventures and associates		25,098		24,457
Investments in securities		2,972		3,246
Deferred tax		5,888		6,454
Retirement benefits1	[1]	9,454		9,151
Trade and other receivables		6,808		6,298
Derivative financial instruments	[2]	348		801
Non-current assets		266,150		272,155
Current assets
Inventories		26,449		26,019
Trade and other receivables		50,619		53,273
Derivative financial instruments	[2]	11,724		15,098
Cash and cash equivalents		38,148		38,774
Current assets other than non-current assets or disposal groups classified as held for sale or as held for distribution to owners		126,940		133,164
Assets classified as held for sale		1,692		951
Current assets		128,632		134,115
Total assets		394,783		406,270
Non-current liabilities
Debt		64,619		71,610
Trade and other payables		4,471		3,103
Derivative financial instruments	[2]	2,438		2,301
Deferred tax		15,293		15,347
Retirement benefits1	[1]	6,701		7,549
Decommissioning and other provisions		22,574		22,531
Non-current liabilities		116,096		122,441
Current liabilities
Debt		10,849		9,931
Trade and other payables		63,943		68,237
Derivative financial instruments	[2]	8,138		9,529
Income taxes payable		4,087		3,422
Decommissioning and other provisions		3,622		4,041
Current liabilities other than liabilities included in disposal groups classified as held for sale		90,639		95,160
Liabilities directly associated with assets classified as held for sale	[1]	857		307
Current liabilities		91,496		95,467
Total liabilities		207,592		217,908
Equity attributable to Shell plc shareholders		185,407		186,607
Non-controlling interest		1,783		1,755
Total equity		187,190		188,362
Total liabilities and equity		$ 394,783		$ 406,270
[1] See Note 8 “Other notes to the unaudited Condensed Consolidated Interim Financial Statements”.

CONSOLIDATED STATEMENT OF CHANG

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY - USD ($) $ in Millions		Total	Total	Share capital	[1]	Shares held in trust	Other reserves	[2]	Retained earnings	Non-controlling interest
Beginning balance at Dec. 31, 2022		$ 192,597	$ 190,472	$ 584		$ (726)	$ 21,132		$ 169,482	$ 2,125
Comprehensive income/(loss) for the period		11,934	11,866				24		11,842	68
Transfer from other comprehensive income		0	0				(121)		121
Dividends	[3]	(4,599)	(4,014)						(4,014)	(585)
Repurchases of shares	[4]	(8,054)	(8,054)	(22)			22		(8,054)
Share-based compensation		192	192			500	(203)		(105)
Other changes		25	1						1	24
Ending balance at Jun. 30, 2023		192,094	190,461	562		(227)	20,854		169,272	1,633
Beginning balance at Dec. 31, 2023		188,362	186,607	544		(997)	21,145		165,915	1,755
Comprehensive income/(loss) for the period		10,560	10,381				(494)		10,874	180
Transfer from other comprehensive income		0	0				170		(170)
Dividends	[3]	(4,537)	(4,387)						(4,387)	(150)
Repurchases of shares	[4]	(7,020)	(7,020)	(17)			17		(7,020)
Share-based compensation		(76)	(76)			544	(213)		(406)
Other changes		(98)	(96)						(96)	(1)
Ending balance at Jun. 30, 2024		$ 187,190	$ 185,407	$ 528		$ (454)	$ 20,625		$ 164,709	$ 1,783
[1] See Note 5 “Share capital”. See Note 6 “Other reserves”. The amount charged to retained earnings is based on prevailing exchange rates on payment date.

CONSOLIDATED STATEMENT OF CASH

CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Millions		3 Months Ended			6 Months Ended
		Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Statement of cash flows [abstract]
Income before taxation for the period		$ 7,404	$ 11,044	$ 5,348	$ 18,447	$ 19,702
Adjustment for:
– Interest expense (net)		619	576	612	1,195	1,276
– Depreciation, depletion and amortisation	[1]	7,555	5,881	7,872	13,436	14,157
– Exploration well write-offs		269	554	204	823	440
– Net (gains)/losses on sale and revaluation of non-current assets and businesses		(143)	(10)	(53)	(154)	(98)
– Share of (profit)/loss of joint ventures and associates		(898)	(1,318)	(629)	(2,216)	(2,210)
– Dividends received from joint ventures and associates		792	738	884	1,530	1,780
– (Increase)/decrease in inventories		(954)	(608)	1,171	(1,562)	5,389
– (Increase)/decrease in current receivables		1,965	(195)	8,289	1,770	14,231
– Increase/(decrease) in current payables	[2]	(1,269)	(1,949)	(4,573)	(3,218)	(15,379)
– Derivative financial instruments		253	1,386	(907)	1,638	(3,244)
– Retirement benefits		(332)	(61)	14	(392)	30
– Decommissioning and other provisions	[2]	(332)	(600)	(282)	(931)	(492)
– Other	[1]	2,027	509	954	2,536	624
Tax paid		(3,448)	(2,616)	(3,773)	(6,064)	(6,917)
Cash flow from operating activities		13,508	13,330	15,130	26,838	29,289
Capital expenditure		(4,445)	(3,980)	(4,614)	(8,424)	(10,774)
Investments in joint ventures and associates		(261)	(500)	(436)	(761)	(743)
Investments in equity securities		(13)	(13)	(80)	(25)	(114)
Cash capital expenditure		(4,719)	(4,493)	(5,130)	(9,211)	(11,631)
Proceeds from sale of property, plant and equipment and businesses		710	323	362	1,033	1,841
Proceeds from joint ventures and associates from sale, capital reduction and repayment of long-term loans		57	133	100	190	357
Proceeds from sale of equity securities		2	569	18	570	20
Interest received		648	577	522	1,224	970
Other investing cash inflows		883	857	1,908	1,740	2,607
Other investing cash outflows		(920)	(1,494)	(794)	(2,414)	(1,417)
Cash flow from investing activities		(3,338)	(3,528)	(3,015)	(6,866)	(7,253)
Net increase/(decrease) in debt with maturity period within three months		(179)	(107)	(186)	(286)	(272)
Other debt:
– New borrowings		132	167	362	299	777
– Repayments		(4,154)	(1,532)	(1,774)	(5,686)	(3,228)
Interest paid		(1,287)	(911)	(1,158)	(2,198)	(2,027)
Derivative financial instruments		(115)	(297)	(152)	(412)	48
Change in non-controlling interest		(1)	(4)	2	(5)	(27)
Cash dividends paid to:
– Shell plc shareholders		(2,177)	(2,210)	(1,983)	(4,387)	(4,013)
– Non-controlling interest		(82)	(68)	(575)	(150)	(585)
Repurchases of shares		(3,958)	(2,824)	(3,624)	(6,782)	(7,915)
Shares held in trust: net sales/(purchases) and dividends received		(24)	(462)	86	(486)	(146)
Cash flow from financing activities		(11,846)	(8,248)	(9,003)	(20,094)	(17,388)
Effects of exchange rate changes on cash and cash equivalents		(126)	(379)	(93)	(505)	199
Increase/(decrease) in cash and cash equivalents		(1,801)	1,175	3,020	(627)	4,848
Cash and cash equivalents at beginning of period		39,949	38,774	42,074	38,774	40,246
Cash and cash equivalents at end of period		$ 38,148	$ 39,949	$ 45,094	$ 38,148	$ 45,094
[1] See Note 8 “Other notes to the unaudited Condensed Consolidated Interim Financial Statements”. To further enhance consistency between working capital and the Balance Sheet and the Statement of Cash Flows, from January 1, 2024, onwards movements in current other provisions are recognised in 'Decommissioning and other provisions' instead of 'Increase/(decrease) in current payables'. Comparatives for the second quarter 2023 and the half year 2023 have been reclassified accordingly by $46 million and $172 million respectively to conform with current period presentation.

CONSOLIDATED STATEMENT OF CAS_2

CONSOLIDATED STATEMENT OF CASH FLOWS (Parentheticals) - USD ($) $ in Millions		3 Months Ended	6 Months Ended
		Jun. 30, 2023	Jun. 30, 2023
Disclosure of reclassifications or changes in presentation [line items]
– Increase/(decrease) in current payables	[1]	$ 4,573	$ 15,379
– Decommissioning and other provisions	[1]	(282)	(492)
Revision of prior period, reclassification, adjustment
Disclosure of reclassifications or changes in presentation [line items]
– Increase/(decrease) in current payables		46	172
– Decommissioning and other provisions		$ 46	$ 172
[1] To further enhance consistency between working capital and the Balance Sheet and the Statement of Cash Flows, from January 1, 2024, onwards movements in current other provisions are recognised in 'Decommissioning and other provisions' instead of 'Increase/(decrease) in current payables'. Comparatives for the second quarter 2023 and the half year 2023 have been reclassified accordingly by $46 million and $172 million respectively to conform with current period presentation.

Basis of preparation

Basis of preparation	6 Months Ended
	Jun. 30, 2024
Disclosure Of Basis Of Preparation Of Financial Statements [Abstract]
Basis of preparation	Basis of preparation These unaudited Condensed Consolidated Interim Financial Statements of Shell plc (“the Company”) and its subsidiaries (collectively referred to as “Shell”) have been prepared in accordance with IAS 34 Interim Financial Reporting as issued by the International Accounting Standards Board ("IASB") and adopted by the UK, and on the basis of the same accounting principles as those used in the Company's Annual Report and Accounts (pages 244 to 316) for the year ended December 31, 2023, as filed with the Registrar of Companies for England and Wales and as filed with the Autoriteit Financiële Markten (the Netherlands) and Form 20-F (pages 217 to 290) for the year ended December 31, 2023 as filed with the US Securities and Exchange Commission, and should be read in conjunction with these filings. The financial information presented in the unaudited Condensed Consolidated Interim Financial Statements does not constitute statutory accounts within the meaning of section 434(3) of the Companies Act 2006 (“the Act”). Statutory accounts for the year ended December 31, 2023, were published in Shell's Annual Report and Accounts, a copy of which was delivered to the Registrar of Companies for England and Wales, and in Shell's Form 20-F. The auditor's report on those accounts was unqualified, did not include a reference to any matters to which the auditor drew attention by way of emphasis without qualifying the report and did not contain a statement under sections 498(2) or 498(3) of the Act. Going Concern These unaudited Condensed Consolidated Interim Financial Statements have been prepared on the going concern basis of accounting. In assessing the appropriateness of the going concern assumption over the period to December 31, 2025 (the ‘going concern period’), management have stress tested Shell’s most recent financial projections to incorporate a range of potential future outcomes by considering Shell’s principal risks, potential downside pressures on commodity prices and long-term demand, and cash preservation measures, including reduced cash capital expenditure and shareholder distributions. This assessment confirmed that Shell has adequate cash, other liquid resources and undrawn credit facilities to enable it to meet its obligations as they fall due in order to continue its operations during the going concern period. Therefore, the Directors consider it appropriate to continue to adopt the going concern basis of accounting in preparing these unaudited Condensed Consolidated Interim Financial Statements.

Segment information

Segment information	6 Months Ended
	Jun. 30, 2024
Operating Segments [Abstract]
Segment information	Segment information REVENUE AND CCS EARNINGS BY SEGMENT Segment earnings are presented on a current cost of supplies basis (CCS earnings), which is the earnings measure used by the Chief Executive Officer for the purposes of making decisions about allocating resources and assessing performance. On this basis, the purchase price of volumes sold during the period is based on the current cost of supplies during the same period after making allowance for the tax effect. CCS earnings therefore exclude the effect of changes in the oil price on inventory carrying amounts. Sales between segments are based on prices generally equivalent to commercially available prices. From the first quarter 2024, Wholesale commercial fuels forms part of Mobility with inclusion in the Marketing segment (previously Chemicals and Products segment). The change in segmentation reflects the increasing alignment between the economic characteristics of wholesale commercial fuels and other Mobility businesses, and is consistent with changes in the information provided to the Chief Operating Decision Maker. Prior period comparatives have been revised to conform with current year presentation with an offsetting impact between the Marketing and the Chemicals and Products segment (see below). Also, from the first quarter 2024, Shell's longer-term innovation portfolio is managed centrally and hence reported as part of the Corporate segment (previously all other segments). Prior period comparatives have been revised to conform with current year presentation with an offsetting impact on all the other segments (see below). Quarters $ million Half year Q2 2024 Q1 2024 Q2 2023 2024 2023 Third-party revenue 9,052 9,195 7,938 Integrated Gas 18,247 18,869 1,590 1,759 1,533 Upstream 3,349 3,595 32,005 30,041 31,517 Marketing 2 62,045 63,562 24,583 23,735 23,712 Chemicals and Products 2 48,319 50,002 7,222 7,737 9,866 Renewables and Energy Solutions 14,959 25,485 11 11 12 Corporate 22 24 74,463 72,478 74,578 Total third-party revenue 1 146,942 161,538 Inter-segment revenue 2,157 2,404 2,940 Integrated Gas 4,560 6,474 10,102 10,287 8,859 Upstream 20,390 20,005 1,363 1,355 1,273 Marketing 2 2,718 2,600 9,849 10,312 9,918 Chemicals and Products 2 20,161 20,711 957 1,005 771 Renewables and Energy Solutions 1,962 2,246 — — — Corporate — — CCS earnings 2,454 2,761 757 Integrated Gas 5,215 3,169 2,179 2,272 1,601 Upstream 4,451 4,390 257 774 1,019 Marketing 2 1,031 2,203 587 1,157 307 Chemicals and Products 2 1,744 2,060 (75) 553 540 Renewables and Energy Solutions 478 2,745 (1,656) (354) (736) Corporate 3 (2,010) (1,818) 3,747 7,163 3,488 Total CCS earnings 4 10,910 12,749 1. Includes revenue from sources other than from contracts with customers, which mainly comprises the impact of fair value accounting of commodity derivatives. Second quarter 2024 included income of $3,194 million (first quarter 2024: $1,643 million income; second quarter 2023: $4,247 million income). This amount includes both the reversal of prior losses of $73 million (first quarter 2024: $257 million gains; second quarter 2023: $27 million gains) related to sales contracts and prior losses of $227 million (first quarter 2024: $235 million losses; second quarter 2023: $88 million losses) related to purchase contracts that were previously recognised and where physical settlement took place in the second quarter 2024. 2. From January 1, 2024, onwards Wholesale commercial fuels has been reallocated from the Chemicals and Products segment to the Marketing segment. Comparatives for the second quarter 2023 and the half year 2023 have been reclassified accordingly, by $4,944 million and $10,710 million respectively for Third-party revenue and by $48 million and $95 million respectively for CCS earnings to conform with current period presentation. For Inter-segment revenue the reallocation and revision of comparative figures for the second quarter 2023 and the half year 2023 led to an increase in inter-segment revenue in the Marketing segment of $1,150 million and $2,314 million respectively and an increase in the Chemicals and Products segment of $9,410 million and $19,638 million respectively. 3. From January 1, 2024, onwards costs for Shell's centrally managed longer-term innovation portfolio are reported as part of the Corporate segment. Prior period comparatives for Corporate for the second quarter 2023 and the half year 2023 have been revised by $35 million and $53 million respectively, with a net offsetting impact in all other segments to conform with current period presentation. 4. See Note 3 "Reconciliation of income for the period to CCS Earnings, Operating expenses and Total Debt". CASH CAPITAL EXPENDITURE BY SEGMENT Cash capital expenditure is a measure used by the Chief Executive Officer for the purposes of making decisions about allocating resources and assessing performance. Quarters $ million Half year Q2 2024 Q1 2024 Q2 2023 2024 2023 Capital expenditure 1,024 858 803 Integrated Gas 1,882 1,500 1,769 1,766 1,936 Upstream 3,535 3,688 644 427 695 Marketing 1 1,071 3,423 601 474 624 Chemicals and Products 1 1,074 1,183 377 421 483 Renewables and Energy Solutions 797 858 30 34 72 Corporate 64 122 4,445 3,980 4,614 Total capital expenditure 8,424 10,774 Add: Investments in joint ventures and associates 127 184 286 Integrated Gas 310 401 60 244 93 Upstream 304 211 – 38 14 Marketing 38 23 37 26 3 Chemicals and Products 63 5 35 8 46 Renewables and Energy Solutions 43 91 1 – (6) Corporate 2 10 261 500 436 Total investments in joint ventures and associates 761 743 Add: Investments in equity securities – – – Integrated Gas – – – – – Upstream – – – – – Marketing – – – – 2 Chemicals and Products – 2 13 10 27 Renewables and Energy Solutions 22 46 – 3 51 Corporate 3 65 13 13 80 Total investments in equity securities 25 114 Cash capital expenditure 1,151 1,041 1,089 Integrated Gas 2,192 1,901 1,829 2,010 2,029 Upstream 3,839 3,899 644 465 709 Marketing 1 1,109 3,446 638 500 630 Chemicals and Products 1 1,138 1,190 425 438 556 Renewables and Energy Solutions 863 996 32 37 117 Corporate 69 198 4,719 4,493 5,130 Total Cash capital expenditure 9,211 11,631 1. From January 1, 2024, onwards Wholesale commercial fuels has been reallocated from the Chemicals and Products segment to the Marketing segment. Comparatives for the second quarter 2023 and the half year 2023 have been reclassified accordingly by $39 million and $91 million respectively for capital expenditure and cash capital expenditure to conform with current period presentation. Reconciliation of income for the period to CCS Earnings, Operating expenses and Total Debt RECONCILIATION OF INCOME FOR THE PERIOD TO CCS EARNINGS Quarters $ million Half year Q2 2024 Q1 2024 Q2 2023 2024 2023 3,517 7,358 3,134 Income/(loss) attributable to Shell plc shareholders 10,874 11,843 133 82 20 Income/(loss) attributable to non-controlling interest 215 83 3,650 7,439 3,154 Income/(loss) for the period 11,089 11,926 Current cost of supplies adjustment: 137 (332) 383 Purchases (194) 1,030 (36) 84 (96) Taxation 48 (267) (5) (28) 47 Share of profit/(loss) of joint ventures and associates (33) 60 97 (276) 334 Current cost of supplies adjustment (179) 823 Of which: 89 (264) 326 Attributable to Shell plc shareholders (175) 807 7 (12) 8 Attributable to non-controlling interest (4) 16 3,747 7,163 3,488 CCS earnings 10,910 12,749 Of which: 3,606 7,093 3,460 CCS earnings attributable to Shell plc shareholders 10,700 12,650 140 70 27 CCS earnings attributable to non-controlling interest 210 99 RECONCILIATION OF OPERATING EXPENSES Quarters $ million Half year Q2 2024 Q1 2024 Q2 2023 2024 2023 5,593 5,810 6,041 Production and manufacturing expenses 11,403 12,049 3,094 2,975 3,314 Selling, distribution and administrative expenses 6,069 6,365 263 212 297 Research and development 475 550 8,950 8,997 9,653 Operating expenses 17,947 18,964 RECONCILIATION OF TOTAL DEBT Quarters $ million Half year Q2 2024 Q1 2024 Q2 2023 2024 2023 June 30, 2024 March 31, 2024 June 30, 2023 June 30, 2024 June 30, 2023 10,849 11,046 12,114 Current debt 10,849 12,114 64,619 68,886 72,252 Non-current debt 64,619 72,252 75,468 79,931 84,366 Total debt 75,468 84,366

Reconciliation of income for th

Reconciliation of income for the period to CCS Earnings, Operating expenses and Total Debt	6 Months Ended
	Jun. 30, 2024
Operating Segments [Abstract]
Reconciliation of income for the period to CCS Earnings, Operating expenses and Total Debt	Segment information REVENUE AND CCS EARNINGS BY SEGMENT Segment earnings are presented on a current cost of supplies basis (CCS earnings), which is the earnings measure used by the Chief Executive Officer for the purposes of making decisions about allocating resources and assessing performance. On this basis, the purchase price of volumes sold during the period is based on the current cost of supplies during the same period after making allowance for the tax effect. CCS earnings therefore exclude the effect of changes in the oil price on inventory carrying amounts. Sales between segments are based on prices generally equivalent to commercially available prices. From the first quarter 2024, Wholesale commercial fuels forms part of Mobility with inclusion in the Marketing segment (previously Chemicals and Products segment). The change in segmentation reflects the increasing alignment between the economic characteristics of wholesale commercial fuels and other Mobility businesses, and is consistent with changes in the information provided to the Chief Operating Decision Maker. Prior period comparatives have been revised to conform with current year presentation with an offsetting impact between the Marketing and the Chemicals and Products segment (see below). Also, from the first quarter 2024, Shell's longer-term innovation portfolio is managed centrally and hence reported as part of the Corporate segment (previously all other segments). Prior period comparatives have been revised to conform with current year presentation with an offsetting impact on all the other segments (see below). Quarters $ million Half year Q2 2024 Q1 2024 Q2 2023 2024 2023 Third-party revenue 9,052 9,195 7,938 Integrated Gas 18,247 18,869 1,590 1,759 1,533 Upstream 3,349 3,595 32,005 30,041 31,517 Marketing 2 62,045 63,562 24,583 23,735 23,712 Chemicals and Products 2 48,319 50,002 7,222 7,737 9,866 Renewables and Energy Solutions 14,959 25,485 11 11 12 Corporate 22 24 74,463 72,478 74,578 Total third-party revenue 1 146,942 161,538 Inter-segment revenue 2,157 2,404 2,940 Integrated Gas 4,560 6,474 10,102 10,287 8,859 Upstream 20,390 20,005 1,363 1,355 1,273 Marketing 2 2,718 2,600 9,849 10,312 9,918 Chemicals and Products 2 20,161 20,711 957 1,005 771 Renewables and Energy Solutions 1,962 2,246 — — — Corporate — — CCS earnings 2,454 2,761 757 Integrated Gas 5,215 3,169 2,179 2,272 1,601 Upstream 4,451 4,390 257 774 1,019 Marketing 2 1,031 2,203 587 1,157 307 Chemicals and Products 2 1,744 2,060 (75) 553 540 Renewables and Energy Solutions 478 2,745 (1,656) (354) (736) Corporate 3 (2,010) (1,818) 3,747 7,163 3,488 Total CCS earnings 4 10,910 12,749 1. Includes revenue from sources other than from contracts with customers, which mainly comprises the impact of fair value accounting of commodity derivatives. Second quarter 2024 included income of $3,194 million (first quarter 2024: $1,643 million income; second quarter 2023: $4,247 million income). This amount includes both the reversal of prior losses of $73 million (first quarter 2024: $257 million gains; second quarter 2023: $27 million gains) related to sales contracts and prior losses of $227 million (first quarter 2024: $235 million losses; second quarter 2023: $88 million losses) related to purchase contracts that were previously recognised and where physical settlement took place in the second quarter 2024. 2. From January 1, 2024, onwards Wholesale commercial fuels has been reallocated from the Chemicals and Products segment to the Marketing segment. Comparatives for the second quarter 2023 and the half year 2023 have been reclassified accordingly, by $4,944 million and $10,710 million respectively for Third-party revenue and by $48 million and $95 million respectively for CCS earnings to conform with current period presentation. For Inter-segment revenue the reallocation and revision of comparative figures for the second quarter 2023 and the half year 2023 led to an increase in inter-segment revenue in the Marketing segment of $1,150 million and $2,314 million respectively and an increase in the Chemicals and Products segment of $9,410 million and $19,638 million respectively. 3. From January 1, 2024, onwards costs for Shell's centrally managed longer-term innovation portfolio are reported as part of the Corporate segment. Prior period comparatives for Corporate for the second quarter 2023 and the half year 2023 have been revised by $35 million and $53 million respectively, with a net offsetting impact in all other segments to conform with current period presentation. 4. See Note 3 "Reconciliation of income for the period to CCS Earnings, Operating expenses and Total Debt". CASH CAPITAL EXPENDITURE BY SEGMENT Cash capital expenditure is a measure used by the Chief Executive Officer for the purposes of making decisions about allocating resources and assessing performance. Quarters $ million Half year Q2 2024 Q1 2024 Q2 2023 2024 2023 Capital expenditure 1,024 858 803 Integrated Gas 1,882 1,500 1,769 1,766 1,936 Upstream 3,535 3,688 644 427 695 Marketing 1 1,071 3,423 601 474 624 Chemicals and Products 1 1,074 1,183 377 421 483 Renewables and Energy Solutions 797 858 30 34 72 Corporate 64 122 4,445 3,980 4,614 Total capital expenditure 8,424 10,774 Add: Investments in joint ventures and associates 127 184 286 Integrated Gas 310 401 60 244 93 Upstream 304 211 – 38 14 Marketing 38 23 37 26 3 Chemicals and Products 63 5 35 8 46 Renewables and Energy Solutions 43 91 1 – (6) Corporate 2 10 261 500 436 Total investments in joint ventures and associates 761 743 Add: Investments in equity securities – – – Integrated Gas – – – – – Upstream – – – – – Marketing – – – – 2 Chemicals and Products – 2 13 10 27 Renewables and Energy Solutions 22 46 – 3 51 Corporate 3 65 13 13 80 Total investments in equity securities 25 114 Cash capital expenditure 1,151 1,041 1,089 Integrated Gas 2,192 1,901 1,829 2,010 2,029 Upstream 3,839 3,899 644 465 709 Marketing 1 1,109 3,446 638 500 630 Chemicals and Products 1 1,138 1,190 425 438 556 Renewables and Energy Solutions 863 996 32 37 117 Corporate 69 198 4,719 4,493 5,130 Total Cash capital expenditure 9,211 11,631 1. From January 1, 2024, onwards Wholesale commercial fuels has been reallocated from the Chemicals and Products segment to the Marketing segment. Comparatives for the second quarter 2023 and the half year 2023 have been reclassified accordingly by $39 million and $91 million respectively for capital expenditure and cash capital expenditure to conform with current period presentation. Reconciliation of income for the period to CCS Earnings, Operating expenses and Total Debt RECONCILIATION OF INCOME FOR THE PERIOD TO CCS EARNINGS Quarters $ million Half year Q2 2024 Q1 2024 Q2 2023 2024 2023 3,517 7,358 3,134 Income/(loss) attributable to Shell plc shareholders 10,874 11,843 133 82 20 Income/(loss) attributable to non-controlling interest 215 83 3,650 7,439 3,154 Income/(loss) for the period 11,089 11,926 Current cost of supplies adjustment: 137 (332) 383 Purchases (194) 1,030 (36) 84 (96) Taxation 48 (267) (5) (28) 47 Share of profit/(loss) of joint ventures and associates (33) 60 97 (276) 334 Current cost of supplies adjustment (179) 823 Of which: 89 (264) 326 Attributable to Shell plc shareholders (175) 807 7 (12) 8 Attributable to non-controlling interest (4) 16 3,747 7,163 3,488 CCS earnings 10,910 12,749 Of which: 3,606 7,093 3,460 CCS earnings attributable to Shell plc shareholders 10,700 12,650 140 70 27 CCS earnings attributable to non-controlling interest 210 99 RECONCILIATION OF OPERATING EXPENSES Quarters $ million Half year Q2 2024 Q1 2024 Q2 2023 2024 2023 5,593 5,810 6,041 Production and manufacturing expenses 11,403 12,049 3,094 2,975 3,314 Selling, distribution and administrative expenses 6,069 6,365 263 212 297 Research and development 475 550 8,950 8,997 9,653 Operating expenses 17,947 18,964 RECONCILIATION OF TOTAL DEBT Quarters $ million Half year Q2 2024 Q1 2024 Q2 2023 2024 2023 June 30, 2024 March 31, 2024 June 30, 2023 June 30, 2024 June 30, 2023 10,849 11,046 12,114 Current debt 10,849 12,114 64,619 68,886 72,252 Non-current debt 64,619 72,252 75,468 79,931 84,366 Total debt 75,468 84,366

Earnings per share

Earnings per share	6 Months Ended
	Jun. 30, 2024
Earnings per share [abstract]
Earnings per Share	Earnings per share EARNINGS PER SHARE Quarters Half year Q2 2024 Q1 2024 Q2 2023 2024 2023 3,517 7,358 3,134 Income/(loss) attributable to Shell plc shareholders ($ million) 10,874 11,843 Weighted average number of shares used as the basis for determining: 6,355.4 6,440.1 6,793.4 Basic earnings per share (million) 6,397.7 6,855.8 6,417.6 6,504.3 6,854.2 Diluted earnings per share (million) 6,461.0 6,917.8

Share capital

Share capital	6 Months Ended
	Jun. 30, 2024
Share Capital, Reserves And Other Equity Interest [Abstract]
Share capital	Share capital ISSUED AND FULLY PAID ORDINARY SHARES OF €0.07 EACH Number of shares Nominal value At January 1, 2024 6,524,109,049 544 Repurchases of shares (199,993,563) (17) At June 30, 2024 6,324,115,486 528 At January 1, 2023 7,003,503,393 584 Repurchases of shares (268,292,487) (22) At June 30, 2023 6,735,210,906 562

Other reserves

Other reserves	6 Months Ended
	Jun. 30, 2024
Share Capital, Reserves And Other Equity Interest [Abstract]
Other reserves	Other reserves OTHER RESERVES $ million Merger reserve Share premium reserve Capital redemption reserve Share plan reserve Accumulated other comprehensive income Total At January 1, 2024 37,298 154 236 1,308 (17,851) 21,145 Other comprehensive income/(loss) attributable to Shell plc shareholders — — — — (494) (494) Transfer from other comprehensive income — — — — 170 170 Repurchases of shares — — 17 — — 17 Share-based compensation — — — (213) — (213) At June 30, 2024 37,298 154 253 1,095 (18,175) 20,625 At January 1, 2023 37,298 154 196 1,140 (17,656) 21,132 Other comprehensive income/(loss) attributable to Shell plc shareholders — — — — 24 24 Transfer from other comprehensive income — — — — (121) (121) Repurchases of shares — — 22 — — 22 Share-based compensation — — — (203) — (203) At June 30, 2023 37,298 154 220 936 (17,752) 20,854

Derivative financial instrument

Derivative financial instruments and debt excluding lease liabilities	6 Months Ended
	Jun. 30, 2024
Financial Instruments [Abstract]
Derivative financial instruments and debt excluding lease liabilities	Derivative financial instruments and debt excluding lease liabilities As disclosed in the Consolidated Financial Statements for the year ended December 31, 2023, presented in the Annual Report and Accounts and Form 20-F for that year, Shell is exposed to the risks of changes in fair value of its financial assets and liabilities. The fair values of the financial assets and liabilities are defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Methods and assumptions used to estimate the fair values at June 30, 2024, are consistent with those used in the year ended December 31, 2023, though the carrying amounts of derivative financial instruments have changed since that date. The movement of the derivative financial instruments between December 31, 2023 and June 30, 2024 is a decrease of $3,374 million for the current assets and a decrease of $1,391 million for the current liabilities. The table below provides the comparison of the fair value with the carrying amount of debt excluding lease liabilities, disclosed in accordance with IFRS 7 Financial Instruments: Disclosures. DEBT EXCLUDING LEASE LIABILITIES $ million June 30, 2024 December 31, 2023 Carrying amount 49,868 53,832 Fair value¹ 45,803 50,866 1 .

Other notes to the unaudited Co

Other notes to the unaudited Condensed Consolidated Interim Financial Statements	6 Months Ended
	Jun. 30, 2024
Other notes to the unaudited Condensed Consolidated Interim Financial Statements [Abstract]
Other notes to the unaudited Condensed Consolidated Interim Financial Statements	8. Other notes to the unaudited Condensed Consolidated Interim Financial Statements Consolidated Statement of Income Interest and other income Quarters $ million Half year Q2 2024 Q1 2024 Q2 2023 2024 2023 (305) 907 813 Interest and other income/(expenses) 602 1,294 Of which: 616 588 599 Interest income 1,204 1,100 30 23 29 Dividend income (from investments in equity securities) 53 29 143 10 65 Net gains/(losses) on sales and revaluation of non-current assets and businesses 154 110 (1,169) 66 7 Net foreign exchange gains/(losses) on financing activities (1,103) (229) 74 219 113 Other 293 284 Net foreign exchange gains/(losses) on financing activities in the second quarter 2024 includes a loss of $1,104 million related to cumulative currency translation differences that were reclassified to profit and loss. The reclassification of these cumulative currency translation differences was principally triggered by changes in the funding structure of some of Shell's businesses in the United Kingdom. These currency translation differences were previously directly recognised in equity as part of accumulated other comprehensive income. Depreciation, depletion and amortisation Quarters $ million Half year Q2 2024 Q1 2024 Q2 2023 2024 2023 7,555 5,881 7,872 Depreciation, depletion and amortisation 13,436 14,157 Of which: 5,642 5,654 5,708 Depreciation 11,296 11,404 1,984 382 2,490 Impairments 2,365 3,079 (71) (154) (326) Impairment reversals (225) (326) Impairments recognised in the second quarter 2024 of $1,984 million pre-tax ($1,778 million post-tax) mainly relate to Marketing ($1,055 million), Chemicals and Products ($690 million) and Renewables and Energy Solutions ($141 million). The impairment in Marketing principally relates to a biofuels facility located in the Netherlands, triggered by a temporary pause of on-site construction work. The impairment in Chemicals and Products relates to an Energy and Chemicals Park located in Singapore, due to remeasurement of the fair value less costs of disposal triggered by a sales agreement reached. Impairments recognised in the first quarter 2024 of $382 million pre-tax ($332 million post-tax) include various smaller impairments in various segments. Impairments in the second quarter 2023 were mainly triggered by a change in the discount rate applied. Impairments recognised in the second quarter 2023 of $2,490 million pre-tax ($1,910 million post-tax) relate to an asset in Integrated Gas located in North America and various smaller impairments across segments. Taxation charge/credit Quarters $ million Half year Q2 2024 Q1 2024 Q2 2023 2024 2023 3,754 3,604 2,195 Taxation charge/(credit) 7,358 7,776 Of which: 3,666 3,525 2,195 Income tax excluding Pillar Two income tax 7,192 7,776 88 79 — Income tax related to Pillar Two income tax 167 — On June 20, 2023, the UK substantively enacted Pillar Two Model Rules, effective as from January 1, 2024. As required by IAS 12 Income Taxes, Shell has applied the exception to recognising and disclosing information about deferred tax assets and liabilities related to Pillar Two income taxes. Consolidated Statement of Comprehensive Income Currency translation differences Quarters $ million Half year Q2 2024 Q1 2024 Q2 2023 2024 2023 698 (1,995) (267) Currency translation differences (1,296) 286 Of which: (406) (1,983) (263) Recognised in Other comprehensive income (2,388) 288 1,104 (12) (4) (Gain)/loss reclassified to profit or loss 1,092 (2) Amounts reclassified to profit and loss in the second quarter 2024 relate to cumulative currency translation differences that were reclassified to income (refer to Interest and other income above). Condensed Consolidated Balance Sheet Retirement benefits $ million June 30, 2024 December 31, 2023 Non-current assets Retirement benefits 9,454 9,151 Non-current liabilities Retirement benefits 6,701 7,549 Surplus/(deficit) 2,753 1,602 Amounts recognised in the Balance Sheet in relation to defined benefit plans include both plan assets and obligations that are presented on a net basis on a plan-by-plan basis. The change in the net retirement benefit asset as at June 30, 2024, is mainly driven by an increase of the market yield on high-quality corporate bonds in the USA, the UK and Eurozone since December 31, 2023, partly offset by losses on plan assets. Assets classified as held for sale $ million June 30, 2024 December 31, 2023 Assets classified as held for sale 1,692 951 Liabilities directly associated with assets classified as held for sale 857 307 Assets classified as held for sale and associated liabilities at June 30, 2024 relate to an energy and chemicals park asset in Chemicals and Products in Singapore and various smaller assets. The major classes of assets and liabilities classified as held for sale at June 30, 2024, are Inventories ($1,310 million; December 31, 2023: $463 million), Property, plant and equipment ($215 million; December 31, 2023: $250 million), Debt ($377 million; December 31, 2023: $84 million) and Decommissioning and other provisions ($329 million; December 31, 2023: $75 million). Consolidated Statement of Cash Flows Cash flow from operating activities - Other Quarters $ million Half year Q2 2024 Q1 2024 Q2 2023 2024 2023 2,027 509 954 Other 2,536 624

Segment information (Tables)

Segment information (Tables)	6 Months Ended
	Jun. 30, 2024
Operating Segments [Abstract]
Summary of Information by Segment	Quarters $ million Half year Q2 2024 Q1 2024 Q2 2023 2024 2023 Third-party revenue 9,052 9,195 7,938 Integrated Gas 18,247 18,869 1,590 1,759 1,533 Upstream 3,349 3,595 32,005 30,041 31,517 Marketing 2 62,045 63,562 24,583 23,735 23,712 Chemicals and Products 2 48,319 50,002 7,222 7,737 9,866 Renewables and Energy Solutions 14,959 25,485 11 11 12 Corporate 22 24 74,463 72,478 74,578 Total third-party revenue 1 146,942 161,538 Inter-segment revenue 2,157 2,404 2,940 Integrated Gas 4,560 6,474 10,102 10,287 8,859 Upstream 20,390 20,005 1,363 1,355 1,273 Marketing 2 2,718 2,600 9,849 10,312 9,918 Chemicals and Products 2 20,161 20,711 957 1,005 771 Renewables and Energy Solutions 1,962 2,246 — — — Corporate — — CCS earnings 2,454 2,761 757 Integrated Gas 5,215 3,169 2,179 2,272 1,601 Upstream 4,451 4,390 257 774 1,019 Marketing 2 1,031 2,203 587 1,157 307 Chemicals and Products 2 1,744 2,060 (75) 553 540 Renewables and Energy Solutions 478 2,745 (1,656) (354) (736) Corporate 3 (2,010) (1,818) 3,747 7,163 3,488 Total CCS earnings 4 10,910 12,749 1. Includes revenue from sources other than from contracts with customers, which mainly comprises the impact of fair value accounting of commodity derivatives. Second quarter 2024 included income of $3,194 million (first quarter 2024: $1,643 million income; second quarter 2023: $4,247 million income). This amount includes both the reversal of prior losses of $73 million (first quarter 2024: $257 million gains; second quarter 2023: $27 million gains) related to sales contracts and prior losses of $227 million (first quarter 2024: $235 million losses; second quarter 2023: $88 million losses) related to purchase contracts that were previously recognised and where physical settlement took place in the second quarter 2024. 2. From January 1, 2024, onwards Wholesale commercial fuels has been reallocated from the Chemicals and Products segment to the Marketing segment. Comparatives for the second quarter 2023 and the half year 2023 have been reclassified accordingly, by $4,944 million and $10,710 million respectively for Third-party revenue and by $48 million and $95 million respectively for CCS earnings to conform with current period presentation. For Inter-segment revenue the reallocation and revision of comparative figures for the second quarter 2023 and the half year 2023 led to an increase in inter-segment revenue in the Marketing segment of $1,150 million and $2,314 million respectively and an increase in the Chemicals and Products segment of $9,410 million and $19,638 million respectively. 3. From January 1, 2024, onwards costs for Shell's centrally managed longer-term innovation portfolio are reported as part of the Corporate segment. Prior period comparatives for Corporate for the second quarter 2023 and the half year 2023 have been revised by $35 million and $53 million respectively, with a net offsetting impact in all other segments to conform with current period presentation. 4. See Note 3 "Reconciliation of income for the period to CCS Earnings, Operating expenses and Total Debt". Quarters $ million Half year Q2 2024 Q1 2024 Q2 2023 2024 2023 Capital expenditure 1,024 858 803 Integrated Gas 1,882 1,500 1,769 1,766 1,936 Upstream 3,535 3,688 644 427 695 Marketing 1 1,071 3,423 601 474 624 Chemicals and Products 1 1,074 1,183 377 421 483 Renewables and Energy Solutions 797 858 30 34 72 Corporate 64 122 4,445 3,980 4,614 Total capital expenditure 8,424 10,774 Add: Investments in joint ventures and associates 127 184 286 Integrated Gas 310 401 60 244 93 Upstream 304 211 – 38 14 Marketing 38 23 37 26 3 Chemicals and Products 63 5 35 8 46 Renewables and Energy Solutions 43 91 1 – (6) Corporate 2 10 261 500 436 Total investments in joint ventures and associates 761 743 Add: Investments in equity securities – – – Integrated Gas – – – – – Upstream – – – – – Marketing – – – – 2 Chemicals and Products – 2 13 10 27 Renewables and Energy Solutions 22 46 – 3 51 Corporate 3 65 13 13 80 Total investments in equity securities 25 114 Cash capital expenditure 1,151 1,041 1,089 Integrated Gas 2,192 1,901 1,829 2,010 2,029 Upstream 3,839 3,899 644 465 709 Marketing 1 1,109 3,446 638 500 630 Chemicals and Products 1 1,138 1,190 425 438 556 Renewables and Energy Solutions 863 996 32 37 117 Corporate 69 198 4,719 4,493 5,130 Total Cash capital expenditure 9,211 11,631 1.

Reconciliation of income for _2

Reconciliation of income for the period to CCS Earnings, Operating expenses and Total Debt (Tables)	6 Months Ended
	Jun. 30, 2024
Operating Segments [Abstract]
Summary of Reconciliation of CCS Earnings to Income	RECONCILIATION OF INCOME FOR THE PERIOD TO CCS EARNINGS Quarters $ million Half year Q2 2024 Q1 2024 Q2 2023 2024 2023 3,517 7,358 3,134 Income/(loss) attributable to Shell plc shareholders 10,874 11,843 133 82 20 Income/(loss) attributable to non-controlling interest 215 83 3,650 7,439 3,154 Income/(loss) for the period 11,089 11,926 Current cost of supplies adjustment: 137 (332) 383 Purchases (194) 1,030 (36) 84 (96) Taxation 48 (267) (5) (28) 47 Share of profit/(loss) of joint ventures and associates (33) 60 97 (276) 334 Current cost of supplies adjustment (179) 823 Of which: 89 (264) 326 Attributable to Shell plc shareholders (175) 807 7 (12) 8 Attributable to non-controlling interest (4) 16 3,747 7,163 3,488 CCS earnings 10,910 12,749 Of which: 3,606 7,093 3,460 CCS earnings attributable to Shell plc shareholders 10,700 12,650 140 70 27 CCS earnings attributable to non-controlling interest 210 99
Summary of Reconciliation of Operating Expenses	RECONCILIATION OF OPERATING EXPENSES Quarters $ million Half year Q2 2024 Q1 2024 Q2 2023 2024 2023 5,593 5,810 6,041 Production and manufacturing expenses 11,403 12,049 3,094 2,975 3,314 Selling, distribution and administrative expenses 6,069 6,365 263 212 297 Research and development 475 550 8,950 8,997 9,653 Operating expenses 17,947 18,964
Summary of Reconciliation of Total Debt	RECONCILIATION OF TOTAL DEBT Quarters $ million Half year Q2 2024 Q1 2024 Q2 2023 2024 2023 June 30, 2024 March 31, 2024 June 30, 2023 June 30, 2024 June 30, 2023 10,849 11,046 12,114 Current debt 10,849 12,114 64,619 68,886 72,252 Non-current debt 64,619 72,252 75,468 79,931 84,366 Total debt 75,468 84,366

Earnings per share (Tables)

Earnings per share (Tables)	6 Months Ended
	Jun. 30, 2024
Earnings per share [abstract]
Schedule of Earnings per Share	EARNINGS PER SHARE Quarters Half year Q2 2024 Q1 2024 Q2 2023 2024 2023 3,517 7,358 3,134 Income/(loss) attributable to Shell plc shareholders ($ million) 10,874 11,843 Weighted average number of shares used as the basis for determining: 6,355.4 6,440.1 6,793.4 Basic earnings per share (million) 6,397.7 6,855.8 6,417.6 6,504.3 6,854.2 Diluted earnings per share (million) 6,461.0 6,917.8

Share capital (Tables)

Share capital (Tables)	6 Months Ended
	Jun. 30, 2024
Share Capital, Reserves And Other Equity Interest [Abstract]
Summary of Issued and Fully Paid Ordinary Shares	ISSUED AND FULLY PAID ORDINARY SHARES OF €0.07 EACH Number of shares Nominal value At January 1, 2024 6,524,109,049 544 Repurchases of shares (199,993,563) (17) At June 30, 2024 6,324,115,486 528 At January 1, 2023 7,003,503,393 584 Repurchases of shares (268,292,487) (22) At June 30, 2023 6,735,210,906 562

Other reserves (Tables)

Other reserves (Tables)	6 Months Ended
	Jun. 30, 2024
Share Capital, Reserves And Other Equity Interest [Abstract]
Summary of Other Reserves Attributable to Royal Dutch Shell Plc Shareholders	OTHER RESERVES $ million Merger reserve Share premium reserve Capital redemption reserve Share plan reserve Accumulated other comprehensive income Total At January 1, 2024 37,298 154 236 1,308 (17,851) 21,145 Other comprehensive income/(loss) attributable to Shell plc shareholders — — — — (494) (494) Transfer from other comprehensive income — — — — 170 170 Repurchases of shares — — 17 — — 17 Share-based compensation — — — (213) — (213) At June 30, 2024 37,298 154 253 1,095 (18,175) 20,625 At January 1, 2023 37,298 154 196 1,140 (17,656) 21,132 Other comprehensive income/(loss) attributable to Shell plc shareholders — — — — 24 24 Transfer from other comprehensive income — — — — (121) (121) Repurchases of shares — — 22 — — 22 Share-based compensation — — — (203) — (203) At June 30, 2023 37,298 154 220 936 (17,752) 20,854

Derivative financial instrume_2

Derivative financial instruments and debt excluding lease liabilities (Tables)	6 Months Ended
	Jun. 30, 2024
Financial Instruments [Abstract]
Comparison of the Fair Value with the Carrying Amount of Debt Excluding Lease Liabilities	The table below provides the comparison of the fair value with the carrying amount of debt excluding lease liabilities, disclosed in accordance with IFRS 7 Financial Instruments: Disclosures. DEBT EXCLUDING LEASE LIABILITIES $ million June 30, 2024 December 31, 2023 Carrying amount 49,868 53,832 Fair value¹ 45,803 50,866 1 .

Other notes to the unaudited _2

Other notes to the unaudited Condensed Consolidated Interim Financial Statements (Tables)	6 Months Ended
	Jun. 30, 2024
Other notes to the unaudited Condensed Consolidated Interim Financial Statements [Abstract]
Interest and other income	Interest and other income Quarters $ million Half year Q2 2024 Q1 2024 Q2 2023 2024 2023 (305) 907 813 Interest and other income/(expenses) 602 1,294 Of which: 616 588 599 Interest income 1,204 1,100 30 23 29 Dividend income (from investments in equity securities) 53 29 143 10 65 Net gains/(losses) on sales and revaluation of non-current assets and businesses 154 110 (1,169) 66 7 Net foreign exchange gains/(losses) on financing activities (1,103) (229) 74 219 113 Other 293 284
Depreciation, depletion and amortisation	Quarters $ million Half year Q2 2024 Q1 2024 Q2 2023 2024 2023 7,555 5,881 7,872 Depreciation, depletion and amortisation 13,436 14,157 Of which: 5,642 5,654 5,708 Depreciation 11,296 11,404 1,984 382 2,490 Impairments 2,365 3,079 (71) (154) (326) Impairment reversals (225) (326)
Taxation charge/ credit	Taxation charge/credit Quarters $ million Half year Q2 2024 Q1 2024 Q2 2023 2024 2023 3,754 3,604 2,195 Taxation charge/(credit) 7,358 7,776 Of which: 3,666 3,525 2,195 Income tax excluding Pillar Two income tax 7,192 7,776 88 79 — Income tax related to Pillar Two income tax 167 —
Currency translation differences	Currency translation differences Quarters $ million Half year Q2 2024 Q1 2024 Q2 2023 2024 2023 698 (1,995) (267) Currency translation differences (1,296) 286 Of which: (406) (1,983) (263) Recognised in Other comprehensive income (2,388) 288 1,104 (12) (4) (Gain)/loss reclassified to profit or loss 1,092 (2)
Retirement benefits	Retirement benefits $ million June 30, 2024 December 31, 2023 Non-current assets Retirement benefits 9,454 9,151 Non-current liabilities Retirement benefits 6,701 7,549 Surplus/(deficit) 2,753 1,602
Assets classified as held for sale	Assets classified as held for sale $ million June 30, 2024 December 31, 2023 Assets classified as held for sale 1,692 951 Liabilities directly associated with assets classified as held for sale 857 307
Cash flows from operating activities - Other	Cash flow from operating activities - Other Quarters $ million Half year Q2 2024 Q1 2024 Q2 2023 2024 2023 2,027 509 954 Other 2,536 624

Segment information - Revenue a

Segment information - Revenue and CCS Earnings by Segment (Details) - USD ($) $ in Millions		3 Months Ended			6 Months Ended
		Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Disclosure of operating segments [line items]
Third-party revenue	[1]	$ 74,463	$ 72,478	$ 74,578	$ 146,942	$ 161,538
Gains on change in fair value of derivatives		3,194	1,643	4,247
Operating segments
Disclosure of operating segments [line items]
Third-party revenue		74,463	72,478	74,578	146,942	161,538
Integrated Gas | Operating segments
Disclosure of operating segments [line items]
Third-party revenue		9,052	9,195	7,938	18,247	18,869
Integrated Gas | Inter-segment
Disclosure of operating segments [line items]
Third-party revenue		2,157	2,404	2,940	4,560	6,474
Upstream | Operating segments
Disclosure of operating segments [line items]
Third-party revenue		1,590	1,759	1,533	3,349	3,595
Upstream | Inter-segment
Disclosure of operating segments [line items]
Third-party revenue		10,102	10,287	8,859	20,390	20,005
Marketing | Operating segments
Disclosure of operating segments [line items]
Third-party revenue		32,005	30,041	31,517	62,045	63,562
Marketing | Operating segments | Revision of prior period, reclassification, adjustment
Disclosure of operating segments [line items]
Third-party revenue				4,944		10,710
Marketing | Inter-segment
Disclosure of operating segments [line items]
Third-party revenue		1,363	1,355	1,273	2,718	2,600
Marketing | Inter-segment | Revision of prior period, reclassification, adjustment
Disclosure of operating segments [line items]
Third-party revenue				1,150		2,314
Chemicals and Products | Operating segments
Disclosure of operating segments [line items]
Third-party revenue		24,583	23,735	23,712	48,319	50,002
Chemicals and Products | Operating segments | Revision of prior period, reclassification, adjustment
Disclosure of operating segments [line items]
Third-party revenue				(4,944)		(10,710)
Chemicals and Products | Inter-segment
Disclosure of operating segments [line items]
Third-party revenue		9,849	10,312	9,918	20,161	20,711
Chemicals and Products | Inter-segment | Revision of prior period, reclassification, adjustment
Disclosure of operating segments [line items]
Third-party revenue				9,410		19,638
Renewables and Energy Solutions | Operating segments
Disclosure of operating segments [line items]
Third-party revenue		7,222	7,737	9,866	14,959	25,485
Renewables and Energy Solutions | Inter-segment
Disclosure of operating segments [line items]
Third-party revenue		957	1,005	771	1,962	2,246
Corporate | Operating segments
Disclosure of operating segments [line items]
Third-party revenue		11	11	12	22	24
Corporate | Inter-segment
Disclosure of operating segments [line items]
Third-party revenue		0	0	0	0	0
CCS earnings
Disclosure of operating segments [line items]
CCS earnings		3,747	7,163	3,488	10,910	12,749
CCS earnings | Integrated Gas
Disclosure of operating segments [line items]
CCS earnings		2,454	2,761	757	5,215	3,169
CCS earnings | Upstream
Disclosure of operating segments [line items]
CCS earnings		2,179	2,272	1,601	4,451	4,390
CCS earnings | Marketing
Disclosure of operating segments [line items]
CCS earnings		257	774	1,019	1,031	2,203
CCS earnings | Marketing | Revision of prior period, reclassification, adjustment
Disclosure of operating segments [line items]
CCS earnings				48		95
CCS earnings | Chemicals and Products
Disclosure of operating segments [line items]
CCS earnings		587	1,157	307	1,744	2,060
CCS earnings | Chemicals and Products | Revision of prior period, reclassification, adjustment
Disclosure of operating segments [line items]
CCS earnings				(48)		(95)
CCS earnings | Renewables and Energy Solutions
Disclosure of operating segments [line items]
CCS earnings		(75)	553	540	478	2,745
CCS earnings | Corporate
Disclosure of operating segments [line items]
CCS earnings		(1,656)	(354)	(736)	$ (2,010)	(1,818)
CCS earnings | Corporate | Revision of prior period, reclassification, adjustment
Disclosure of operating segments [line items]
CCS earnings				35		$ 53
Sales contract
Disclosure of operating segments [line items]
Reversal of (gains) losses on purchase contracts		73	257	27
Purchase contract
Disclosure of operating segments [line items]
Reversal of gains on sales contracts		$ 227	$ 235	$ 88
[1] See Note 2 “Segment information”.

Segment information - Cash Capi

Segment information - Cash Capital Expenditure by Segment (Details) - USD ($) $ in Millions	3 Months Ended			6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Disclosure of operating segments [line items]
Capital expenditure	$ 4,445	$ 3,980	$ 4,614	$ 8,424	$ 10,774
Investments in joint ventures and associates	261	500	436	761	743
Investments in equity securities	13	13	80	25	114
Cash capital expenditure	4,719	4,493	5,130	9,211	11,631
Operating segments
Disclosure of operating segments [line items]
Capital expenditure	4,445	3,980	4,614	8,424	10,774
Investments in joint ventures and associates	261	500	436	761	743
Investments in equity securities	13	13	80	25	114
Cash capital expenditure	4,719	4,493	5,130	9,211	11,631
Operating segments | Integrated Gas
Disclosure of operating segments [line items]
Capital expenditure	1,024	858	803	1,882	1,500
Investments in joint ventures and associates	127	184	286	310	401
Investments in equity securities	0	0	0	0	0
Cash capital expenditure	1,151	1,041	1,089	2,192	1,901
Operating segments | Upstream
Disclosure of operating segments [line items]
Capital expenditure	1,769	1,766	1,936	3,535	3,688
Investments in joint ventures and associates	60	244	93	304	211
Investments in equity securities	0	0	0	0	0
Cash capital expenditure	1,829	2,010	2,029	3,839	3,899
Operating segments | Marketing
Disclosure of operating segments [line items]
Capital expenditure	644	427	695	1,071	3,423
Investments in joint ventures and associates	0	38	14	38	23
Investments in equity securities	0	0	0	0	0
Cash capital expenditure	644	465	709	1,109	3,446
Operating segments | Marketing | Revision of prior period, reclassification, adjustment
Disclosure of operating segments [line items]
Capital expenditure			39
Cash capital expenditure					91
Operating segments | Chemicals and Products
Disclosure of operating segments [line items]
Capital expenditure	601	474	624	1,074	1,183
Investments in joint ventures and associates	37	26	3	63	5
Investments in equity securities	0	0	2	0	2
Cash capital expenditure	638	500	630	1,138	1,190
Operating segments | Chemicals and Products | Revision of prior period, reclassification, adjustment
Disclosure of operating segments [line items]
Capital expenditure			(39)
Cash capital expenditure					(91)
Operating segments | Renewables and Energy Solutions
Disclosure of operating segments [line items]
Capital expenditure	377	421	483	797	858
Investments in joint ventures and associates	35	8	46	43	91
Investments in equity securities	13	10	27	22	46
Cash capital expenditure	425	438	556	863	996
Operating segments | Corporate
Disclosure of operating segments [line items]
Capital expenditure	30	34	72	64	122
Investments in joint ventures and associates	1	0	(6)	2	10
Investments in equity securities	0	3	51	3	65
Cash capital expenditure	$ 32	$ 37	$ 117	$ 69	$ 198

Reconciliation of income for _3

Reconciliation of income for the period to CCS Earnings, Operating expenses and Total Debt - Summary of Reconciliation of Income to CCS Earnings (Details) - USD ($) $ in Millions		3 Months Ended			6 Months Ended
		Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Disclosure Of Reconciliation Of Ccs Earnings To Income [Line Items]
Income/(loss) attributable to Shell plc shareholders		$ 3,517	$ 7,358	$ 3,134	$ 10,874	$ 11,843
Income/(loss) attributable to non-controlling interest		133	82	20	215	83
Income/(loss) for the period	[1]	3,650	7,439	3,154	11,089	11,926
CCS earnings
Current cost of supplies adjustment:
Purchases		137	(332)	383	(194)	1,030
Taxation		(36)	84	(96)	48	(267)
Share of profit/(loss) of joint ventures and associates		(5)	(28)	47	(33)	60
Current cost of supplies adjustment		97	(276)	334	(179)	823
Of which:
Attributable to Shell plc shareholders		89	(264)	326	(175)	807
Attributable to non-controlling interest		7	(12)	8	(4)	16
CCS earnings		3,747	7,163	3,488	10,910	12,749
of which:
CCS earnings attributable to Shell plc shareholders		3,606	7,093	3,460	10,700	12,650
CCS earnings attributable to non-controlling interest		$ 140	$ 70	$ 27	$ 210	$ 99
[1] See Note 2 “Segment information”.

Reconciliation of income for _4

Reconciliation of income for the period to CCS Earnings, Operating expenses and Total Debt - Summary of Reconciliation of Operating Expenses (Details) - USD ($) $ in Millions	3 Months Ended			6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Disclosure Of Reconciliation Of Earnings To Income [Line Items]
Production and manufacturing expenses	$ 5,593	$ 5,810	$ 6,041	$ 11,403	$ 12,049
Selling, distribution and administrative expenses	3,094	2,975	3,314	6,069	6,365
Research and development	263	212	297	475	550
Operating expenses	67,653	63,659	70,671	131,312	145,339
CCS earnings
Disclosure Of Reconciliation Of Earnings To Income [Line Items]
Production and manufacturing expenses	5,593	5,810	6,041	11,403	12,049
Selling, distribution and administrative expenses	3,094	2,975	3,314	6,069	6,365
Research and development	263	212	297	475	550
Operating expenses	$ 8,950	$ 8,997	$ 9,653	$ 17,947	$ 18,964

Reconciliation of income for _5

Reconciliation of income for the period to CCS Earnings, Operating expenses and Total Debt - Summary of Reconciliation of Total Debt (Details) - USD ($) $ in Millions	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Jun. 30, 2023
Disclosure of operating segments [abstract]
Current debt	$ 10,849	$ 11,046	$ 9,931	$ 12,114
Non-current debt	64,619	68,886	$ 71,610	72,252
Total debt	$ 75,468	$ 79,931		$ 84,366

Earnings per share - Schedule o

Earnings per share - Schedule of Earnings per Share (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended			6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Earnings per share [abstract]
Income/(loss) attributable to Shell plc shareholders	$ 3,517	$ 7,358	$ 3,134	$ 10,874	$ 11,843
Weighted average number of shares used as the basis for determining:
Basic earnings per share (in shares)	6,355.4	6,440.1	6,793.4	6,397.7	6,855.8
Diluted earnings per share (in shares)	6,417.6	6,504.3	6,854.2	6,461	6,917.8

Share capital - Summary of Issu

Share capital - Summary of Issued and Fully Paid Ordinary Shares (Details) $ in Millions		6 Months Ended
		Jun. 30, 2024 USD ($) shares	Jun. 30, 2023 USD ($) shares	Jun. 30, 2024 € / shares	Jun. 30, 2023 € / shares
Disclosure of classes of share capital [line items]
Repurchases of shares	[1]	$ (7,020)	$ (8,054)
Share capital
Disclosure of classes of share capital [line items]
Beginning balance (in shares) | shares		6,524,109,049	7,003,503,393
Beginning balance		$ 544	$ 584
Repurchases of shares (in shares) | shares		(199,993,563)	(268,292,487)
Repurchases of shares	[1],[2]	$ (17)	$ (22)
Ending balance (in shares) | shares		6,324,115,486	6,735,210,906
Ending balance		$ 528
Share capital | Ordinary shares
Disclosure of classes of share capital [line items]
Ending balance			$ 562
Class A Shares | Share capital
Disclosure of classes of share capital [line items]
Par value per share (in eur per share) | € / shares				€ 0.07	€ 0.07
[1]Includes shares committed to repurchase under an irrevocable contract and repurchases subject to settlement at the end of the quarter.[2] See Note 5 “Share capital”.

Share capital - Narrative (Deta

Share capital - Narrative (Details) - Ordinary shares issue mandate € / shares in Units, € in Millions, shares in Millions	May 21, 2024 EUR (€) € / shares shares
Disclosure of classes of share capital [line items]
Common stock, value authorised | €	€ 150
Common stock, shares authorised (in shares) | shares	2,147
Par value per share (in eur per share) | € / shares	€ 0.07

Other reserves - Summary of Oth

Other reserves - Summary of Other Reserves Attributable to Royal Dutch Shell Plc Shareholders (Details) - USD ($) $ in Millions		3 Months Ended			6 Months Ended
		Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Disclosure Of Accumulated Other Comprehensive Income Loss [Line Items]
Other comprehensive income/(loss) attributable to Shell plc shareholders		$ 4,443	$ 5,937	$ 2,908	$ 10,381	$ 11,866
Repurchases of shares	[1]				(7,020)	(8,054)
Total
Disclosure Of Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance			21,145		21,145	21,132
Other comprehensive income/(loss) attributable to Shell plc shareholders					(494)	24
Transfer from other comprehensive income					170	(121)
Repurchases of shares	[1],[2]				17	22
Share-based compensation					(213)	(203)
Ending balance		20,625		20,854	20,625	20,854
Merger reserve
Disclosure Of Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance			37,298		37,298	37,298
Other comprehensive income/(loss) attributable to Shell plc shareholders					0	0
Transfer from other comprehensive income					0	0
Repurchases of shares					0	0
Share-based compensation					0	0
Ending balance		37,298		37,298	37,298	37,298
Share premium reserve
Disclosure Of Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance			154		154	154
Other comprehensive income/(loss) attributable to Shell plc shareholders					0	0
Transfer from other comprehensive income					0	0
Repurchases of shares					0	0
Share-based compensation					0	0
Ending balance		154		154	154	154
Capital redemption reserve
Disclosure Of Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance			236		236	196
Other comprehensive income/(loss) attributable to Shell plc shareholders					0	0
Transfer from other comprehensive income					0	0
Repurchases of shares					17	22
Share-based compensation					0	0
Ending balance		253		220	253	220
Share plan reserve
Disclosure Of Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance			1,308		1,308	1,140
Other comprehensive income/(loss) attributable to Shell plc shareholders					0	0
Transfer from other comprehensive income					0	0
Repurchases of shares					0	0
Share-based compensation					(213)	(203)
Ending balance		1,095		936	1,095	936
Accumulated other comprehensive income
Disclosure Of Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance			$ (17,851)		(17,851)	(17,656)
Other comprehensive income/(loss) attributable to Shell plc shareholders					(494)	24
Transfer from other comprehensive income					170	(121)
Repurchases of shares					0	0
Share-based compensation					0	0
Ending balance		$ (18,175)		$ (17,752)	$ (18,175)	$ (17,752)
[1]Includes shares committed to repurchase under an irrevocable contract and repurchases subject to settlement at the end of the quarter.[2] See Note 6 “Other reserves”.

Derivative financial instrume_3

Derivative financial instruments and debt excluding lease liabilities - Narrative (Details) $ in Millions	6 Months Ended
	Jun. 30, 2024 USD ($)
Derivatives
Disclosure of detailed information about financial instruments [line items]
Decrease in financial liabilities	$ 1,391
Derivatives
Disclosure of detailed information about financial instruments [line items]
Decrease in financial assets	$ 3,374

Derivative financial instrume_4

Derivative financial instruments and debt excluding lease liabilities - Comparison of the Fair Value with the Carrying Amount of Debt Excluding Lease Liabilities (Details) - USD ($) $ in Millions	Jun. 30, 2024	Jun. 30, 2023
Financial Instruments [Abstract]
Carrying amount	$ 49,868	$ 53,832
Fair value	$ 45,803	$ 50,866

Other notes to the unaudited _3

Other notes to the unaudited Condensed Consolidated Interim Financial Statements - Interest and Other Income (Details) - USD ($) $ in Millions		3 Months Ended			6 Months Ended
		Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Other notes to the unaudited Condensed Consolidated Interim Financial Statements [Abstract]
Interest and other income/(expenses)	[1]	$ (305)	$ 907	$ 813	$ 602	$ 1,294
Of which:
Interest income		616	588	599	1,204	1,100
Dividend income (from investments in equity securities)		30	23	29	53	29
Net gains/(losses) on sales and revaluation of non-current assets and businesses		143	10	65	154	110
Net foreign exchange gains/(losses) on financing activities		(1,169)	66	7	(1,103)	(229)
Other		$ 74	$ 219	$ 113	$ 293	$ 284
[1] See Note 8 “Other notes to the unaudited Condensed Consolidated Interim Financial Statements”. 3

Other notes to the unaudited _4

Other notes to the unaudited Condensed Consolidated Interim Financial Statements - Income statement narrative (Details) - USD ($) $ in Millions	3 Months Ended			6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Disclosure of impairment loss and reversal of impairment loss [line items]
(Gain)/loss reclassified to profit or loss	$ (1,104)	$ 12	$ 4	$ (1,092)	$ 2
Impairment loss	1,984	382	2,490
Impairment loss, after tax	1,778	$ 332	$ 1,910
Marketing
Disclosure of impairment loss and reversal of impairment loss [line items]
Impairment loss	1,055
Chemicals and Products
Disclosure of impairment loss and reversal of impairment loss [line items]
Impairment loss	690
Renewables and Energy Solutions
Disclosure of impairment loss and reversal of impairment loss [line items]
Impairment loss	$ 141

Other notes to the unaudited _5

Other notes to the unaudited Condensed Consolidated Interim Financial Statements - Depreciation, depletion and amortisation (Details) - USD ($) $ in Millions		3 Months Ended			6 Months Ended
		Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Impairment Of Assets [Abstract]
Total depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss	[1]	$ 7,555	$ 5,881	$ 7,872	$ 13,436	$ 14,157
Depreciation		5,642	5,654	5,708	11,296	11,404
Impairments		1,984	382	2,490	2,365	3,079
Impairment reversals		$ (71)	$ (154)	$ (326)	$ (225)	$ (326)
[1] See Note 8 “Other notes to the unaudited Condensed Consolidated Interim Financial Statements”. 3

Other notes to the unaudited _6

Other notes to the unaudited Condensed Consolidated Interim Financial Statements - Taxation charge/ credit (Details) - USD ($) $ in Millions		3 Months Ended			6 Months Ended
		Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Major components of tax expense (income) [abstract]
Taxation charge/(credit)	[1]	$ 3,754	$ 3,604	$ 2,195	$ 7,358	$ 7,776
Of which:
Income tax excluding Pillar Two income tax		3,666	3,525	2,195	7,192	7,776
Income tax related to Pillar Two income tax		$ 88	$ 79	$ 0	$ 167	$ 0
[1] See Note 8 “Other notes to the unaudited Condensed Consolidated Interim Financial Statements”. 3

Other notes to the unaudited _7

Other notes to the unaudited Condensed Consolidated Interim Financial Statements - Currency translation differences (Details) - USD ($) $ in Millions		3 Months Ended			6 Months Ended
		Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Other notes to the unaudited Condensed Consolidated Interim Financial Statements [Abstract]
– Currency translation differences	[1]	$ 698	$ (1,995)	$ (267)	$ (1,296)	$ 286
Of which:
Recognised in Other comprehensive income		(406)	(1,983)	(263)	(2,388)	288
(Gain)/loss reclassified to profit or loss		$ 1,104	$ (12)	$ (4)	$ 1,092	$ (2)
[1] 1. See Note 8 “Other notes to the unaudited Condensed Consolidated Interim Financial Statements”.

Other notes to the unaudited _8

Other notes to the unaudited Condensed Consolidated Interim Financial Statements - Retirement benefits (Details) - USD ($) $ in Millions		Jun. 30, 2024	Dec. 31, 2023
Other notes to the unaudited Condensed Consolidated Interim Financial Statements [Abstract]
Retirement benefits1	[1]	$ 9,454	$ 9,151
Retirement benefits1	[1]	6,701	7,549
Surplus/(deficit)		$ 2,753	$ 1,602
[1] See Note 8 “Other notes to the unaudited Condensed Consolidated Interim Financial Statements”.

Other notes to the unaudited _9

Other notes to the unaudited Condensed Consolidated Interim Financial Statements - Assets classified as held for sale (Details) - USD ($) $ in Millions		Jun. 30, 2024	Dec. 31, 2023
Other notes to the unaudited Condensed Consolidated Interim Financial Statements [Abstract]
Assets classified as held for sale		$ 1,692	$ 951
Liabilities directly associated with assets classified as held for sale	[1]	$ 857	$ 307
[1] See Note 8 “Other notes to the unaudited Condensed Consolidated Interim Financial Statements”.

Other notes to the unaudited_10

Other notes to the unaudited Condensed Consolidated Interim Financial Statements - Balance Sheet/Cash Flow Narrative (Details) - USD ($) $ in Millions	3 Months Ended			6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Disclosure of depreciation, depletion and amortisation [Line Items]
Inventories	$ 26,449			$ 26,449		$ 26,019
Property, plant and equipment	189,656			189,656		194,835
Total debt	75,468	$ 79,931	$ 84,366	75,468	$ 84,366
Decommissioning and other provisions	3,622			3,622		4,041
(Gain)/loss reclassified to profit or loss	1,104	(12)	(4)	1,092	$ (2)
Decrease (increase) in emissions instruments	(620)	188	764
Adjustments For Reversal (Increase) In Recyled Currency Translation Losses (Gains)	1,104	$ 0	$ 0
Assets and liabilities classified as held for sale
Disclosure of depreciation, depletion and amortisation [Line Items]
Inventories	1,310			1,310		463
Property, plant and equipment	215			215		250
Total debt	377			377		84
Decommissioning and other provisions	$ 329			$ 329		$ 75

Other notes to the unaudited_11

Other notes to the unaudited Condensed Consolidated Interim Financial Statements - Other cash flows (Details) - USD ($) $ in Millions		3 Months Ended			6 Months Ended
		Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Other notes to the unaudited Condensed Consolidated Interim Financial Statements [Abstract]
Other operating cash inflows	[1]	$ 2,027	$ 509	$ 954	$ 2,536	$ 624
[1] See Note 8 “Other notes to the unaudited Condensed Consolidated Interim Financial Statements”.